Swiss Pharmaceutical giant Roche was urged to cut the cost of a groundbreaking breast cancer drug that Britain's National Health Service is set to phase out in 2016.
Anti-Breast Cancer Drugs may Now Penetrate the Blood Brain Barrier
While some breast cancer drugs penetrate the blood brain barrier, they do not work effectively, whereas some others do not penetrate at all, yet work effectively
While some breast cancer drugs penetrate the blood brain barrier, they do not work effectively, whereas some others do not penetrate at all, yet work effectively
The drug, which attacks cancerous cells from within thus avoiding many of the side effects of chemotherapy, could potentially help a fifth of breast cancer sufferers.
NICE chief executive Andrew Dillon called on the Swiss firm to review its pricing.
For Greater-risk Women, Breast Cancer Drugs Proposed
Under draft guidelines published, women with a family history of breast cancer who are thought to be at greater risk of developing the disease could be offered drugs aimed at preventing it.
Under draft guidelines published, women with a family history of breast cancer who are thought to be at greater risk of developing the disease could be offered drugs aimed at preventing it.
Roche argues that the price of the drug must take into account costly research and development liabilities.
Advertisement
Scientists are Spinning Results of Trials for Breast Cancer Drugs, Says New Study
A new study reveals that a large number of scientists are “spinning” the results of clinical trials for new breast cancer drugs.
A new study reveals that a large number of scientists are “spinning” the results of clinical trials for new breast cancer drugs.
Study Eliminates Commonly Used Breast Cancer Drugs as Possible Cause for Joint Pain
Inflammatory arthritis and autoimmune disease have been eliminated as possible causes to why some women who take a common breast cancer drug develop serious joint pain, researches explored.
Inflammatory arthritis and autoimmune disease have been eliminated as possible causes to why some women who take a common breast cancer drug develop serious joint pain, researches explored.
